<DOC>
	<DOCNO>NCT02997813</DOCNO>
	<brief_summary>This retrospective observational cohort database analysis . The study review retrospectively records patient undergo first peripheral blood stem cell mobilization multiple myeloma databases approximately 15 hospital part IFM collaborative group . Patient record divide two group 50 patient minimum , maximum 100 patient number patient record could extract . The first group patient receive plerixafor plus G-CSF without administration chemotherapy mobilization strategy second group patient receive cyclophosphamide plus G-CSF mobilization strategy . All consecutive patient complete set data ( underwent apheresis ) treat 2009 2013 G-CSF plerixafor consecutive patient complete data ( underwent apheresis ) treat 2009 2013 G-CSF cyclophosphamide include . All data analyze extract select IFM institution locate France .</brief_summary>
	<brief_title>Assessment Mobilization Cost Multiple Myeloma Using 2 Different Mobilization Strategies</brief_title>
	<detailed_description />
	<mesh_term>Multiple Myeloma</mesh_term>
	<mesh_term>Neoplasms , Plasma Cell</mesh_term>
	<mesh_term>Cyclophosphamide</mesh_term>
	<criteria>Hematology patient diagnose Multiple Myeloma candidate autologous hematopoietic stem cell transplantation ( ASCT ) upfront . Age &gt; 18 year Undergone prior successful peripheral blood stem cell mobilization Cyclophosphamid Plerixafor Age &lt; 18 year ; Primary diagnosis Multiple Myeloma</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>